A patent review of sirtuin activators: an update

Author： Villalba José M   de Cabo Rafael   Alcain Francisco J  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.4, 2012-04, pp. : 355-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel glucokinase activators: a patent review (2008 – 2010)

By Sarabu Ramakanth   Berthel Steven J   Kester Robert F   Tilley Jefferson W  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 13-33

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor ligands: a patent review update

By Paterni Ilaria   Bertini Simone   Granchi Carlotta   Macchia Marco   Minutolo Filippo  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1247-1271

Informa Healthcare

Access to resources Recommend Favorite

Direct AMP-activated protein kinase activators: a review of evidence from the patent literature

By Giordanetto Fabrizio   Karis David  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1467-1477

Informa Healthcare

Access to resources Recommend Favorite

Update on carbonic anhydrase inhibitors: a patent review (2008 – 2011)

By Aggarwal Mayank   McKenna Robert  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 903-915

Informa Healthcare

Access to resources Recommend Favorite

Genitourinary tract patent update

By Smith C.P.   Chancellor M.B.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 17-31

Informa Healthcare

Access to resources Recommend Favorite